The Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...

While the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the ...

Glenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...

If successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...

Favipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in Septembe...

The company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...

The Hyderabad-based producer of active pharmaceutical ingredients (APIs) had in May commercialised the Favipiravir API and is currently dis...

Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...

Results from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6 per cent faster viral clearance in...

“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...

On Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...

Favipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid...

"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...

Favipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...

Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group on Friday announced the start of the final stage o...

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...

Strides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...